Encompass Health Analyst Ratings
Encompass Health Analyst Ratings
涵蓋健康分析師評級
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
09/28/2023 | 23.79% | RBC Capital | → $83 | Reiterates | Outperform → Outperform |
08/08/2023 | 23.79% | RBC Capital | $70 → $83 | Maintains | Outperform |
08/04/2023 | 4.4% | Barclays | $61 → $70 | Maintains | Equal-Weight |
08/04/2023 | 19.31% | Credit Suisse | $76 → $80 | Maintains | Outperform |
08/03/2023 | 26.77% | Raymond James | $80 → $85 | Maintains | Strong Buy |
08/03/2023 | 22.3% | Truist Securities | $75 → $82 | Maintains | Buy |
08/03/2023 | 14.84% | Mizuho | $74 → $77 | Maintains | Buy |
08/03/2023 | 5.89% | Barclays | $61 → $71 | Maintains | Equal-Weight |
07/20/2023 | 16.33% | Stephens & Co. | → $78 | Reiterates | Overweight → Overweight |
06/29/2023 | 16.33% | Stephens & Co. | $74 → $78 | Maintains | Overweight |
05/02/2023 | 4.4% | RBC Capital | $66 → $70 | Maintains | Outperform |
05/02/2023 | 19.31% | Raymond James | $72 → $80 | Maintains | Strong Buy |
05/01/2023 | 8.87% | Deutsche Bank | $70 → $73 | Maintains | Buy |
05/01/2023 | 10.37% | Stephens & Co. | $70 → $74 | Maintains | Overweight |
05/01/2023 | 13.35% | Credit Suisse | $73 → $76 | Maintains | Outperform |
05/01/2023 | 10.37% | Mizuho | $69 → $74 | Maintains | Buy |
04/28/2023 | 10.37% | B of A Securities | $69 → $74 | Maintains | Buy |
04/04/2023 | -9.02% | Barclays | $57 → $61 | Maintains | Equal-Weight |
03/14/2023 | -14.99% | Barclays | → $57 | Initiates Coverage On | → Equal-Weight |
02/09/2023 | 11.86% | Truist Securities | $70 → $75 | Maintains | Buy |
02/09/2023 | 8.87% | Credit Suisse | $62 → $73 | Maintains | Outperform |
02/09/2023 | 2.91% | Mizuho | $65 → $69 | Maintains | Buy |
02/08/2023 | 4.4% | Stephens & Co. | → $70 | Maintains | Overweight |
10/28/2022 | -13.5% | Stephens & Co. | $60 → $58 | Maintains | Overweight |
10/28/2022 | 7.38% | Raymond James | $65 → $72 | Maintains | Strong Buy |
09/21/2022 | -7.53% | Credit Suisse | $63 → $62 | Maintains | Outperform |
08/24/2022 | -1.57% | RBC Capital | $82 → $66 | Maintains | Outperform |
08/08/2022 | -3.06% | Truist Securities | $75 → $65 | Maintains | Buy |
08/04/2022 | -3.06% | BMO Capital | $83 → $65 | Maintains | Outperform |
08/04/2022 | -3.06% | Raymond James | $70 → $65 | Maintains | Strong Buy |
08/04/2022 | -6.04% | Barclays | $80 → $63 | Maintains | Overweight |
06/21/2022 | 11.86% | Truist Securities | $85 → $75 | Maintains | Buy |
06/21/2022 | 10.37% | Stephens & Co. | $78 → $74 | Maintains | Overweight |
06/17/2022 | 4.4% | Raymond James | $85 → $70 | Maintains | Strong Buy |
06/10/2022 | 22.3% | Credit Suisse | $83 → $82 | Maintains | Outperform |
06/08/2022 | 22.3% | RBC Capital | $85 → $82 | Maintains | Outperform |
05/03/2022 | 26.77% | RBC Capital | $104 → $85 | Maintains | Outperform |
05/02/2022 | 26.77% | Raymond James | $80 → $85 | Maintains | Strong Buy |
04/29/2022 | 23.79% | Credit Suisse | $82 → $83 | Maintains | Outperform |
02/07/2022 | 19.31% | Raymond James | $90 → $80 | Maintains | Strong Buy |
11/03/2021 | 19.31% | Mizuho | $94 → $80 | Maintains | Buy |
11/02/2021 | 34.23% | Raymond James | $107 → $90 | Maintains | Strong Buy |
10/13/2021 | 31.25% | Truist Securities | $100 → $88 | Maintains | Buy |
09/24/2021 | 46.16% | UBS | → $98 | Initiates Coverage On | → Buy |
08/02/2021 | 59.58% | Raymond James | $95 → $107 | Upgrades | Outperform → Strong Buy |
07/29/2021 | 55.11% | RBC Capital | $102 → $104 | Maintains | Outperform |
07/29/2021 | 46.16% | Credit Suisse | $96 → $98 | Maintains | Outperform |
07/02/2021 | 55.11% | Deutsche Bank | $87 → $104 | Upgrades | Hold → Buy |
04/29/2021 | 41.69% | Raymond James | $90 → $95 | Maintains | Outperform |
01/28/2021 | 37.21% | Credit Suisse | $97 → $92 | Maintains | Outperform |
11/30/2020 | 34.23% | Raymond James | $78 → $90 | Maintains | Outperform |
11/23/2020 | 43.18% | Barclays | → $96 | Upgrades | Equal-Weight → Overweight |
11/02/2020 | 26.77% | Credit Suisse | $89 → $85 | Maintains | Outperform |
11/02/2020 | 16.33% | Raymond James | $86 → $78 | Maintains | Outperform |
07/27/2020 | 28.26% | Jefferies | $90 → $86 | Maintains | Buy |
05/01/2020 | 34.23% | UBS | $96 → $90 | Maintains | Buy |
04/30/2020 | 28.26% | Raymond James | $90 → $86 | Maintains | Outperform |
03/06/2020 | 43.18% | UBS | $95 → $96 | Maintains | Buy |
03/06/2020 | 23.79% | Deutsche Bank | $73 → $83 | Maintains | Hold |
03/05/2020 | 49.14% | Baird | $85 → $100 | Maintains | Outperform |
03/05/2020 | 34.23% | Mizuho | $87 → $90 | Maintains | Buy |
03/05/2020 | 49.14% | Stephens & Co. | $91 → $100 | Maintains | Overweight |
02/10/2020 | 29.75% | Mizuho | $84 → $87 | Maintains | Buy |
02/10/2020 | 49.14% | SunTrust Robinson Humphrey | $90 → $100 | Maintains | Buy |
01/15/2020 | 32.74% | Credit Suisse | $77 → $89 | Maintains | Outperform |
01/14/2020 | 31.25% | BMO Capital | $85 → $88 | Maintains | Outperform |
01/10/2020 | 29.75% | UBS | $80 → $87 | Maintains | Buy |
12/11/2019 | 1.42% | Wells Fargo | → $68 | Downgrades | Equal-Weight → Underweight |
09/17/2019 | 4.4% | Deutsche Bank | → $70 | Initiates Coverage On | → Hold |
09/06/2019 | — | B of A Securities | Upgrades | Neutral → Buy | |
07/31/2019 | 11.86% | Raymond James | $80 → $75 | Maintains | Outperform |
06/27/2019 | 7.38% | BMO Capital | → $72 | Initiates Coverage On | → Outperform |
05/30/2019 | 4.4% | Barclays | $68 → $70 | Upgrades | Equal-Weight → Overweight |
12/20/2018 | — | Jefferies | Initiates Coverage On | → Buy | |
12/14/2018 | 11.86% | Barclays | → $75 | Initiates Coverage On | → Equal-Weight |
11/16/2018 | 28.26% | UBS | → $86 | Initiates Coverage On | → Buy |
日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
---|---|---|---|---|---|
09/28/2023 | 23.79% | 加拿大皇家銀行資本 | →$83 | 重申 | 跑贏→跑贏大盤 |
2023/08/08 | 23.79% | 加拿大皇家銀行資本 | $70→$83 | 維護 | 跑贏大盤 |
08/04/2023 | 4.4% | 巴克萊 | $61→$70 | 維護 | 等重 |
08/04/2023 | 19.31% | 瑞士信貸 | $76→$80 | 維護 | 跑贏大盤 |
08/03/2023 | 26.77% | 雷蒙德·詹姆斯 | $80→$85 | 維護 | 強勢購買 |
08/03/2023 | 22.3% | Truist證券 | $75→$82 | 維護 | 買 |
08/03/2023 | 14.84% | 瑞穗 | $74→$77 | 維護 | 買 |
08/03/2023 | 5.89% | 巴克萊 | $61→$71 | 維護 | 等重 |
07/20/2023 | 16.33% | 斯蒂芬斯公司 | →$78 | 重申 | 超重→超重 |
2023年6月29日 | 16.33% | 斯蒂芬斯公司 | $74→$78 | 維護 | 超重 |
05/02/2023 | 4.4% | 加拿大皇家銀行資本 | $66→$70 | 維護 | 跑贏大盤 |
05/02/2023 | 19.31% | 雷蒙德·詹姆斯 | $72→$80 | 維護 | 強勢購買 |
05/01/2023 | 8.87% | 德意志銀行 | $70→$73 | 維護 | 買 |
05/01/2023 | 10.37% | 斯蒂芬斯公司 | $70→$74 | 維護 | 超重 |
05/01/2023 | 13.35% | 瑞士信貸 | $73→$76 | 維護 | 跑贏大盤 |
05/01/2023 | 10.37% | 瑞穗 | $69→$74 | 維護 | 買 |
04/28/2023 | 10.37% | B of A證券 | $69→$74 | 維護 | 買 |
04/04/2023 | -9.02% | 巴克萊 | $57→$61 | 維護 | 等重 |
03/14/2023 | -14.99% | 巴克萊 | →$57 | 開始承保 | →等重 |
02/09/2023 | 11.86% | Truist證券 | $70→$75 | 維護 | 買 |
02/09/2023 | 8.87% | 瑞士信貸 | $62→$73 | 維護 | 跑贏大盤 |
02/09/2023 | 2.91% | 瑞穗 | $65→$69 | 維護 | 買 |
02/08/2023 | 4.4% | 斯蒂芬斯公司 | →$70 | 維護 | 超重 |
10/28/2022 | -13.5% | 斯蒂芬斯公司 | $60→$58 | 維護 | 超重 |
10/28/2022 | 7.38% | 雷蒙德·詹姆斯 | $65→$72 | 維護 | 強勢購買 |
2022/09/21 | -7.53% | 瑞士信貸 | $63→$62 | 維護 | 跑贏大盤 |
2022年08月24日 | -1.57% | 加拿大皇家銀行資本 | $82→$66 | 維護 | 跑贏大盤 |
2022/08/08 | -3.06% | Truist證券 | $75→$65 | 維護 | 買 |
08/04/2022 | -3.06% | 蒙特利爾銀行資本 | $83→$65 | 維護 | 跑贏大盤 |
08/04/2022 | -3.06% | 雷蒙德·詹姆斯 | $70→$65 | 維護 | 強勢購買 |
08/04/2022 | -6.04% | 巴克萊 | $80→$63 | 維護 | 超重 |
2022年06月21日 | 11.86% | Truist證券 | $85→$75 | 維護 | 買 |
2022年06月21日 | 10.37% | 斯蒂芬斯公司 | $78→$74 | 維護 | 超重 |
06/17/2022 | 4.4% | 雷蒙德·詹姆斯 | $85→$70 | 維護 | 強勢購買 |
2022/10/06 | 22.3% | 瑞士信貸 | $83→$82 | 維護 | 跑贏大盤 |
06/08/2022 | 22.3% | 加拿大皇家銀行資本 | $85→$82 | 維護 | 跑贏大盤 |
05/03/2022 | 26.77% | 加拿大皇家銀行資本 | $104→$85 | 維護 | 跑贏大盤 |
05/02/2022 | 26.77% | 雷蒙德·詹姆斯 | $80→$85 | 維護 | 強勢購買 |
04/29/2022 | 23.79% | 瑞士信貸 | $82→$83 | 維護 | 跑贏大盤 |
02/07/2022 | 19.31% | 雷蒙德·詹姆斯 | $90→$80 | 維護 | 強勢購買 |
11/03/2021 | 19.31% | 瑞穗 | $94→$80 | 維護 | 買 |
11/02/2021 | 34.23% | 雷蒙德·詹姆斯 | $107→$90 | 維護 | 強勢購買 |
10/13/2021 | 31.25% | Truist證券 | $100→$88 | 維護 | 買 |
09/24/2021 | 46.16% | 瑞銀集團 | →$98 | 開始承保 | →購買 |
08/02/2021 | 59.58% | 雷蒙德·詹姆斯 | $95→$107 | 升級 | 跑贏→強勢買入 |
07/29/2021 | 55.11% | 加拿大皇家銀行資本 | $102→$104 | 維護 | 跑贏大盤 |
07/29/2021 | 46.16% | 瑞士信貸 | $96→$98 | 維護 | 跑贏大盤 |
07/02/2021 | 55.11% | 德意志銀行 | $87→$104 | 升級 | 持有→購買 |
04/29/2021 | 41.69% | 雷蒙德·詹姆斯 | $90→$95 | 維護 | 跑贏大盤 |
2021年1月28日 | 37.21% | 瑞士信貸 | $97→$92 | 維護 | 跑贏大盤 |
11/30/2020 | 34.23% | 雷蒙德·詹姆斯 | $78→$90 | 維護 | 跑贏大盤 |
11/23/2020 | 43.18% | 巴克萊 | →$96 | 升級 | 等重→超重 |
11/02/2020 | 26.77% | 瑞士信貸 | $89→$85 | 維護 | 跑贏大盤 |
11/02/2020 | 16.33% | 雷蒙德·詹姆斯 | $86→$78 | 維護 | 跑贏大盤 |
07/27/2020 | 28.26% | 傑富瑞 | $90→$86 | 維護 | 買 |
05/01/2020 | 34.23% | 瑞銀集團 | $96→$90 | 維護 | 買 |
04/30/2020 | 28.26% | 雷蒙德·詹姆斯 | $90→$86 | 維護 | 跑贏大盤 |
03/06/2020 | 43.18% | 瑞銀集團 | $95→$96 | 維護 | 買 |
03/06/2020 | 23.79% | 德意志銀行 | $73→$83 | 維護 | 保持 |
03/05/2020 | 49.14% | 貝爾德 | $85→$100 | 維護 | 跑贏大盤 |
03/05/2020 | 34.23% | 瑞穗 | $87→$90 | 維護 | 買 |
03/05/2020 | 49.14% | 斯蒂芬斯公司 | $91→$100 | 維護 | 超重 |
02/10/2020 | 29.75% | 瑞穗 | $84→$87 | 維護 | 買 |
02/10/2020 | 49.14% | SunTrust Robinson Humphrey | $90→$100 | 維護 | 買 |
2020/01/15 | 32.74% | 瑞士信貸 | $77→$89 | 維護 | 跑贏大盤 |
2020/01/14 | 31.25% | 蒙特利爾銀行資本 | $85→$88 | 維護 | 跑贏大盤 |
2020/10/01 | 29.75% | 瑞銀集團 | $80→$87 | 維護 | 買 |
2019年12月11日 | 1.42% | 富國銀行 | →$68 | 評級下調 | 等重→減碼 |
2019/09/17 | 4.4% | 德意志銀行 | →$70 | 開始承保 | →保留 |
2019年06月09日 | - | B of A證券 | 升級 | 中性→購買 | |
2019年07月31日 | 11.86% | 雷蒙德·詹姆斯 | $80→$75 | 維護 | 跑贏大盤 |
2019年06月27日 | 7.38% | 蒙特利爾銀行資本 | →$72 | 開始承保 | →跑贏大盤 |
2019年05月30日 | 4.4% | 巴克萊 | $68→$70 | 升級 | 等重→超重 |
2018年12月20日 | - | 傑富瑞 | 開始承保 | →購買 | |
2018年12月14日 | 11.86% | 巴克萊 | →$75 | 開始承保 | →等重 |
2018年11月16日 | 28.26% | 瑞銀集團 | →$86 | 開始承保 | →購買 |
What is the target price for Encompass Health (EHC)?
Enneass Health(EHC)的目標價格是多少?
There is no price target for Encompass Health
Enneass Health沒有設定價格目標
What is the most recent analyst rating for Encompass Health (EHC)?
Enneass Health(EHC)的最新分析師評級是多少?
There is no analyst for Encompass Health
沒有針對Enneass Health的分析師
When is the next analyst rating going to be posted or updated for Encompass Health (EHC)?
Endrass Health(EHC)的下一次分析師評級將於何時發佈或更新?
There is no next analyst rating for Encompass Health
目前還沒有針對Enneass Health的下一個分析師評級
Is the Analyst Rating Encompass Health (EHC) correct?
分析師評級包括健康(EHC)正確嗎?
There is no next analyst rating for Encompass Health
目前還沒有針對Enneass Health的下一個分析師評級